Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EPA/ALDVI stock hub

EPA/ALDVI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/ALDVIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.3M

Euronext Paris

Market data

Price

Recent price action with selectable time range.

EPA/ALDVIEPA/ALDVI

—

Loading chart…

In the news

Latest news · EPA/ALDVI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/ALDVI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

159

Groups with data

Currency

EUR

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	13
Employees Change	-8%
Employees Change Percent	-38.1
Enterprise value	EUR 30M
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FR0013296746
Last refreshed	2026-05-10
Market cap	EUR 12.3M
Price	EUR 0.87
Price currency	EUR
Rev Per Employee	559,615.38x
Sector	Healthcare
Sic	2834
Symbol	epa/ALDVI
Website	https://www.advicenne.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-77.33%
EV Earnings	-3.15x
EV/FCF	-7.3x
EV/Sales	4.12x
FCF yield	-33.34%
P/B ratio	-0.47x
P/S ratio	1.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-114.86%
EBITDA Margin	-80.04%
Gross margin	4.77%
Gross Profit	EUR 347,000
Gross Profit Growth5 Y	-26.95%
Net Income	EUR -9.5M
Net Income Growth Years	0%
Pretax Margin	-136.51%
Profit Margin	-131.02%
Profit Per Employee	EUR -733,231
ROA	-62.74
Roa5y	-44.19
ROCE	138.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-50.04%
Cagr3y	-36.23%
Cagr5y	-39.92%
EPS Growth Years	0
Revenue Growth	27.07x
Revenue Growth Q	23.81x
Revenue Growth Years	3x
Revenue Growth3 Y	5.3x
Revenue Growth5 Y	21.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.87
Assets	EUR 7.1M
Cash	EUR 1.3M
Current Assets	EUR 6.1M
Current Liabilities	EUR 10.3M
Debt	EUR 19M
Debt FCF	EUR -4.62
Equity	EUR -26.4M
Interest Coverage	-5.49
Liabilities	EUR 33.5M
Long Term Assets	EUR 1M
Long Term Liabilities	EUR 23.2M
Net Cash	EUR -17.7M
Net Cash By Market Cap	EUR -143
Tangible Book Value	EUR -26.8M
WACC	7.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.48
Inventory Turnover	4.67
Net Working Capital	EUR -8.2M
Quick ratio	0.36
Working Capital	EUR -6.8M
Working Capital Turnover	EUR -0.91

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-50.02%
200-day SMA	1.61
3Y total return	-74.08%
50-day SMA	1.58
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.17%
All Time High	16.25
All Time High Change	-94.65%
All Time High Date	2021-02-16
All Time Low	0.8
All Time Low Change	8.21%
All Time Low Date	2026-05-06
ATR	0.09
Beta	0.98
Beta1y	0.6
Beta2y	0.11
Ch YTD	-49.71
High	0.88
High52	2.35
High52 Date	2026-02-06
High52ch	-62.98%
Low	0.86
Low52	0.8
Low52 Date	2026-05-06
Low52ch	8.21%
Ma50ch	-45.08%
Price vs 200-day SMA	-46.03%
RSI	21.15
RSI Monthly	38.21
RSI Weekly	26.86
Sharpe ratio	-0.59x
Sortino ratio	-0.74
Tr YTD	-49.71
Tr1m	-42.08%
Tr1w	-29.27%
Tr3m	-59.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -8.4M
Operating margin	-114.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,285,500%
Shares Institutions	4.38%
Shares Out	14,167,933
Shares Qo Q	0.51%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -4.1M
Average Volume	45,747.15x
CAPEX	EUR -382,000
Ch1m	-42.08
Ch1w	-29.27
Ch1y	-50.11
Ch3m	-59.72
Ch3y	-74.6
Ch5y	-92.33
Ch6m	-46.76
Change	0.58%
Change From Open	1.28
Close	0.87
Days Gap	-0.69
Depreciation Amortization	2,533,000
Dollar Volume	30,217.7
Earnings Date	2026-09-17
EBIT	EUR -8.4M
EBITDA	EUR -5.8M
F Score	3
FCF	EUR -4.1M
FCF EV Yield	-13.71x
FCF Per Share	EUR -0.29
Financing CF	2,227,000
Fiscal Year End	December
Founded	2,007
Income Tax	EUR -399,000
Investing CF	-403,000
Is Primary Listing	1
Last Earnings Date	2026-03-26
Last Report Date	2025-06-30
Ma150	1.71
Ma150ch	-49.18%
Ma20	1.25
Ma20ch	-30.18%
Net CF	-1,903,000
Next Earnings Date	2026-09-17
Open	0.86
Position In Range	64.71
Ppne	132,000
Price Date	2026-05-08
Relative Volume	0.76x
Revenue	7,275,000x
Tax By Revenue	-5.48x
Tr6m	-46.76%
Volume	34,733

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EPA/ALDVI pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/ALDVI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EPA/ALDVI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.4%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

EPA/ALDVI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

21.1

Below 30: short-term oversold

Price vs 200-day MA

-46.0%

50/200-day relationship not available

Beta (5Y)

0.98

Moves roughly with the market

Sharpe ratio

-0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/ALDVI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/ALDVI stock rating?

epa/ALDVI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/ALDVI analysis?

The full report lives at /stocks/epa/ALDVI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/ALDVI?

The latest report frames epa/ALDVI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/ALDVI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.